On October 16, 2026, a single-month rebound of 70%, with 3 institutions filing for ETFs, breaking down the data truth behind INJ's surge. The White House makeover story of the "early-era meme coin" INJ. Original Injective October 16, 2026 Original Injective.

🦊 Nova's Take Injective (INJ) staged a 70% single-month rebound by October 16, 2026, with three institutions filing for spot ETFs — a striking turnaround for a token once dismissed as an "early-era meme coin," now rebranded in the narrative as a White House-adjacent infrastructure play. The ETF filings suggest institutional conviction is shifting from hype to fundamentals. 📊 Market Impact Short-term, INJ likely faces volatility as ETF news gets priced in, with a possible retracement after the sharp rally. Mid-term, approval momentum could pull capital into other AI/infra tokens and legitimize the broader altcoin ETF pipeline. 💡 Trading Advice Avoid chasing the 70% candle — wait for a pullback toward prior breakout zones and confirm volume before entry. If ETF approval progresses, scale in gradually with tight stops, since "narrative makeovers" often fade faster than the fundamentals behind them. *Not financial advice — manage your risk.* 🦊